Anand Bhaskar

CIK 00018907842 companiesMIAMI, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001890784

Recent Transactions

29 trades

Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2026-01-08+30,000→ 30,000 total
Award
Summit Therapeutics Inc.$SMMT
Common Stock
2025-10-21$18.74/sh+26,680→ 159,751 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-09-18+50,000→ 50,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-04-29+600,000→ 600,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-04-29+75,000→ 75,000 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2025-01-12+75,000→ 75,000 total
Award
Summit Therapeutics Inc.$SMMT
Common Stock
2024-09-11$22.70/sh+22,026→ 131,426 total
Award
Summit Therapeutics Inc.$SMMT
Stock Option (right to buy)
2024-04-02+600,000→ 600,000 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−33,500→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−15,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−6,000→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-09-26−23,438→ 0 total
Disposition to Issuer
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-26−24,089→ 0 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-09-05$169.20/sh−406→ 24,089 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-08-16$168.42/sh−210→ 24,495 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-08-15$169.06/sh−193→ 24,705 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Class A common stock
2023-06-14$27.32/sh+1,562→ 27,241 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-06-14$102.11/sh−2,343→ 24,898 total
Exercise/Conversion
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2023-06-14−1,562→ 23,438 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-16$81.10/sh−136→ 25,679 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-05-15$85.98/sh−950→ 25,815 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-07$84.58/sh−165→ 26,765 total
Sale
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-03$87.47/sh−820→ 26,930 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-03-01+3,000→ 27,750 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right-to-buy)
2023-03-01+6,000→ 6,000 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2023-01-03+8,250→ 24,750 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right-to-buy)
2023-01-03+33,500→ 33,500 total
Award
REATA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2022-01-03+25,000→ 25,000 total
Award
REATA PHARMACEUTICALS INC
Class A common stock
2022-01-03+12,500→ 16,500 total

Companies

Recent Filings

Address

C/O SUMMIT THERAPEUTICS INC. 601 BRICKELL KEY DRIVE, SUITE 1000

MIAMI, FL, 33131

View on SEC.gov